Nav: Home

Gene activity database could spare thousands of mice

June 28, 2019

A comprehensive database of gene activity in mice across ten disease models, which could significantly reduce animal use worldwide, has been developed by scientists at the Francis Crick Institute, which gives a full picture of the immune response to different pathogens.

The data, published in Nature Communications and available through an online app, shows the activity of every mouse gene - more than 45,000 genes - in the blood of mice with ten different diseases. For the six diseases that involve the lung, samples from lung were also examined.

Previously, researchers would have to create, infect, cull, obtain samples from mice and extract and sequence the RNA to study genes that they are interested in. Using a new app which the lab created for this study, researchers will be able to check the activity of any gene across a range of diseases without needing their own mice. This could prevent thousands of mice being used in individual experiments.

The research team, led by Crick group leader Anne O'Garra and co-ordinated by Christine Graham, worked with many collaborators from the Crick, UK and the USA. They used next-generation sequencing technology, 'RNA-seq', to measure gene activity across the different diseases. As genes need to transcribe their DNA into RNA in order to function, analysing the RNA reveals how active each gene is - in this case after infection or allergen challenge.

"Gene activity can show us how the body responds to infections and allergens," explains Anne. "There are thousands of genes involved in any immune response, so Akul Singhania, a Bioinformatics Postdoc, in our lab used advanced bioinformatics approaches to cluster the genes into modules. These modules represent clusters of genes that are co-regulated and can often be annotated to determine their function and known physiological roles. For example, of 38 lung modules there is a module associated with allergy, and seen only in the allergy model, containing over 100 genes and another module associated with T cells containing over 200 genes."

"By sequencing both lung tissue and blood, we can also see how the immune response in the blood reflects the local response in the lung, and vice versa. This will help us to understand what we can learn from genetic signatures in the blood, since for most diseases doctors can't realistically get lung samples from patients."

A panoply of pathogens

Using the new app, researchers anywhere in the world can look up gene activity in the lungs and blood of mice infected with a range of pathogens: the parasite Toxoplasma gondii, influenza virus and Respiratory Syncytial Virus (RSV), the bacterium Burkholderia pseudomallei, the fungus Candida albicans, or the allergen, house dust mite. They can also see gene activity in the blood of mice with listeria, murine cytomegalovirus, the malaria parasite Plasmodium chabaudi chabaudi, or a chronic Burkholderia pseudomallei infection.

In the study, the research team analysed the genetic signatures associated with these diseases to help understand the immune response. They discovered a broad range of immune responses in the lung, where discrete modules were dominated by genes associated with Type I or Type II interferons, IL-17 or allergy type responses. Type I interferons are known to be released in response to viruses, while Type II interferon (IFN-?) activates phagocytes to kill intracellular pathogens, and IL-17 attracts neutrophils causing early inflammatory immune responses. Interestingly, interferon gene signatures were present in blood modules similarly to the lung, but IL-17 and allergy responses were not.

Surprisingly, genes associated with type I interferon were highly active in both the lungs and blood of mice infected with the Toxoplasma gondii parasite and also seen in response to the Burkholderia pseudomallei bacterium, albeit to a lesser extent. This challenges the view that type I interferon-associated genes are necessarily indicative of viral infections, as the lab had previously shown in tuberculosis.

"We found that mice without functioning interferon pathways were less able to fight off Toxoplasma infection. This was true for both Type I and Type II interferons, which have a complex relationship with each other. We found that both play a key role in protection against the parasite in part by controlling the neutrophils in the blood which in high numbers can cause damage to the host."

From obsolescence to opportunity

The research project began in 2009, using a technique known as microarray to detect gene activity in lung and blood samples and was almost complete and ready to be analysed by 2015. Microarray was then a well-established technique, but the necessary reagents were suddenly discontinued by the manufacturer before the final samples had been processed. Without the equipment to finish the sequencing, the project was in trouble.

With this microarray technology no longer possible, the team needed a different approach. At this time, a technique called RNA-Seq had come onto the market, offering a better way to quantify gene activity.

Following negotiations between Anne and the manufacturer, her team was offered cutting-edge RNA-Seq reagents free of charge, to re process the samples starting in late 2016. They were also provided storage space for the huge amounts of data generated.

As the tissue and blood samples from the microarray experiments were all frozen in storage, Christine Graham in Anne's lab was able to go back to the same samples and heroically process them again, this time for RNA sequencing. Thanks to the excellent storage of the samples, this was possible without use of additional animals. Although time-consuming and a huge task for Christine, by 2018 the team had all the sequencing data they needed.

With a huge amount of data to process, Akul Singhania set about making sense of it all. Using advanced bioinformatics techniques, he clustered the thousands of genes and millions of data points into a meaningful and visual form which we refer to as modules, and created the app to make the data accessible to anyone.

"Ten years since the project began, we now have an open access resource of gene expression that anyone in the world can use to look up their favourite genes and also see if they are regulated by type I or type II interferon signalling," says Anne. "Nobody said science was easy, but it's certainly worthwhile."
-end-


The Francis Crick Institute

Related Immune Response Articles:

Discovering the early age immune response in foals
Researchers at the Cornell University College of Veterinary Medicine have discovered a new method to measure tiny amounts of antibodies in foals, a finding described in the May 16 issue of PLOS ONE.
Nixing the cells that nix immune response against cancer
For first time, study characterizes uptick of myeloid-derived suppressor cells in the spleens of human cancer patients, paving the way for therapies directed against these cells that collude with cancer.
Jumbled chromosomes may dampen the immune response to tumors
How well a tumor responds to immunotherapy may depend in part on whether its chromosomes are intact or in a state of disarray, a new study reports.
Tailored organoid may help unravel immune response mystery
Cornell and Weill Cornell Medicine researchers report on the use of biomaterials-based organoids in an attempt to reproduce immune-system events and gain a better understanding of B cells.
Tweaking the immune response might be a key to combat neurodegeneration
Patients with Alzheimer's or other neurodegenerative diseases progressively loose neurons yet cannot build new ones.
Estrogen signaling impacted immune response in cancer
New research from The Wistar Institute showed that estrogen signaling was responsible for immunosuppressive effects in the tumor microenvironment across cancer types.
No platelets, no immune response
When a virus attacks our organism, an inflammation appears on the affected area.
Malaria: A genetically attenuated parasite induces an immune response
With nearly 3.2 billion people currently at risk of contracting malaria, scientists from the Institut Pasteur, the CNRS and Inserm have experimentally developed a live, genetically attenuated vaccine for Plasmodium, the parasite responsible for the disease.
New finding will help target MS immune response
Researchers have made another important step in the progress towards being able to block the development of multiple sclerosis and other autoimmune diseases.
Flu infection reveals many paths to immune response
A new study of influenza infection in an animal model broadens understanding of how the immune system responds to flu virus, showing that the process is more dynamic than usually described, engaging a broader array of biological pathways.

Related Immune Response Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...